Back
Nurix Therapeutics Stock Price Chart

This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
Sell
34
NRIX
Nurix Therapeutics
Last Price:
$9.78
Seasonality Move:
33.72%
7 Day Trial
ALL ACCESS PASS
$
7

Your Portfolio's Boring. This Company Isn't And It's Early
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio-
The current trend is relatively stagnant and NRIX is experiencing slight buying pressure.
Nurix Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.74 | Buy |
20-day SMA: | 10.35 | Sell |
50-day SMA: | 11.07 | Sell |
200-day SMA: | 18.94 | Sell |
8-day EMA: | 9.8 | Sell |
20-day EMA: | 10.13 | Sell |
50-day EMA: | 11.52 | Sell |
200-day EMA: | 15.89 | Sell |
Nurix Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.45 | Sell |
Relative Strength Index (14 RSI): | 43.24 | Sell |
Chaikin Money Flow: | 47475 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.57 - 11.27) | Sell |
Bollinger Bands (100): | (10.67 - 18.49) | Sell |
Nurix Therapeutics Technical Analysis
May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Nurix Therapeutics Stock
Is Nurix Therapeutics Stock a Buy?
-
Nurix Therapeutics share price is 9.78 while NRIX 8-day simple moving average is 9.74, which is a Buy signal.
-
The stock price of NRIX is 9.78 while Nurix Therapeutics 20-day SMA is 10.35, which makes it a Sell.
-
Nurix Therapeutics 50-day simple moving average is 11.07 while NRIX share price is 9.78, making it a Sell technically.
-
NRIX stock price is 9.78 and Nurix Therapeutics 200-day simple moving average is 18.94, creating a Sell signal.
NRIX Technical Analysis vs Fundamental Analysis
Sell
34
Nurix Therapeutics (NRIX)
is a Sell
Is Nurix Therapeutics a Buy or a Sell?
-
Nurix Therapeutics stock is rated a SellThe current Nurix Therapeutics [NRIX] share price is $9.78. The Score for NRIX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
Nurix Therapeutics Stock Info
Market Cap:
745.6M
Price in USD:
9.78
Share Volume:
640.9K
Nurix Therapeutics 52-Week Range
52-Week High:
29.56
52-Week Low:
8.18
Sell
34
Nurix Therapeutics (NRIX)
is a Sell
Nurix Therapeutics Share Price Forecast
-
What is the Nurix Therapeutics stock price today?The Nurix Therapeutics stock price is 9.78 USD today.
-
Will NRIX stock go up or go down?Nurix Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Nurix Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Nurix Therapeutics is overvalued.
Is Nurix Therapeutics Stock a Buy?
-
Nurix Therapeutics share price is 9.78 while NRIX 8-day exponential moving average is 9.80, which is a Sell signal.
-
The stock price of NRIX is 9.78 while Nurix Therapeutics 20-day EMA is 10.13, which makes it a Sell.
-
Nurix Therapeutics 50-day exponential moving average is 11.52 while NRIX share price is 9.78, making it a Sell technically.
-
NRIX stock price is 9.78 and Nurix Therapeutics 200-day simple moving average is 15.89, creating a Sell signal.
Fundamental Analysis of Nurix Therapeutics
Is Nurix Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.23 per share.
Technical Analysis of Nurix Therapeutics
Should I short Nurix Therapeutics stock?
-
NRIX Moving Average Covergence Divergence (MACD) indicator is -0.45, suggesting Nurix Therapeutics is a Sell
-
Nurix Therapeutics Relative Strength Index (RSI) is 43.24, which suggest Nurix Therapeutics is oversold
-
The Bollinger Bands (25) for Nurix Therapeutics is (9.57 - 11.27), which suggest Nurix Therapeutics is a Sell
-
The Bollinger Bands (100) for Nurix Therapeutics is (10.67 - 18.49), which suggest Nurix Therapeutics is a Sell
* Nurix Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.